These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 27067485)

  • 1. Ferroportin expression and regulation in non-transfusion dependent thalassemia.
    Sonzogni L; Ronzoni L; Graziadei G; Cappellini MD
    Blood Cells Mol Dis; 2016 May; 58():26-8. PubMed ID: 27067485
    [No Abstract]   [Full Text] [Related]  

  • 2. Dysregulation of ferroportin gene expression in β(0)-thalassemia/Hb E disease.
    Sornjai W; Jaratsittisin J; Khungwanmaythawee K; Svasti S; Fucharoen S; Lithanatudom P; Smith DR
    Ann Hematol; 2016 Feb; 95(3):387-96. PubMed ID: 26666535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of alternative transcripts of ferroportin-1 during human erythroid differentiation.
    Cianetti L; Segnalini P; Calzolari A; Morsilli O; Felicetti F; Ramoni C; Gabbianelli M; Testa U; Sposi NM
    Haematologica; 2005 Dec; 90(12):1595-606. PubMed ID: 16330432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron loading in beta-thalassaemia.
    Cazzola M; Alessandrino P; Barosi G; Orlandi E; Ascari E
    Lancet; 1980 Jan; 1(8161):204. PubMed ID: 6101656
    [No Abstract]   [Full Text] [Related]  

  • 5. Growth Differentiation Factor 15 expression and regulation during erythroid differentiation in non-transfusion dependent thalassemia.
    Ronzoni L; Sonzogni L; Duca L; Graziadei G; Cappellini MD; Ferru E
    Blood Cells Mol Dis; 2015 Jan; 54(1):26-8. PubMed ID: 25179833
    [No Abstract]   [Full Text] [Related]  

  • 6. Iron balance in thalassemia.
    Cazzola M; Finch CA
    Prog Clin Biol Res; 1989; 309():93-100. PubMed ID: 2675109
    [No Abstract]   [Full Text] [Related]  

  • 7. Transfusions and erythropoiesis in beta-thalassemia.
    Celada A
    N Engl J Med; 1978 Aug; 299(7):360. PubMed ID: 683271
    [No Abstract]   [Full Text] [Related]  

  • 8. Ferroportin in erythroid cells: a protective mechanism?
    Beaumont C
    Haematologica; 2005 Dec; 90(12):1585. PubMed ID: 16330420
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of iron overload condition on liver toxicity and hepcidin/ferroportin expression in thalassemic mice.
    Kumfu S; Chattipakorn SC; Fucharoen S; Chattipakorn N
    Life Sci; 2016 Apr; 150():15-23. PubMed ID: 26921633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma neutrophil gelatinase-associated lipocalin levels are markedly increased in patients with non-transfusion-dependent thalassemia: Lack of association with markers of erythropoiesis, iron metabolism and renal function.
    Patsaoura A; Tatsi E; Margeli A; Kanavaki I; Delaporta P; Kyriakopoulou D; Kouraklis-Symeonidis A; Kattamis A; Papassotiriou I
    Clin Biochem; 2014 Aug; 47(12):1060-4. PubMed ID: 24721683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron metabolism and iron chelation in the thalassaemia disorders.
    Pippard MJ
    Haematologica; 1990; 75 Suppl 5():66-71. PubMed ID: 2086383
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of thalassaemia major.
    Modell CB
    Arch Dis Child; 1971 Dec; 46(250):878. PubMed ID: 5129195
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepcidin and iron-loading anemias.
    Nemeth E; Ganz T
    Haematologica; 2006 Jun; 91(6):727-32. PubMed ID: 16769573
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhanced erythroid cell differentiation in hypoxic condition is in part contributed by miR-210.
    Sarakul O; Vattanaviboon P; Tanaka Y; Fucharoen S; Abe Y; Svasti S; Umemura T
    Blood Cells Mol Dis; 2013 Aug; 51(2):98-103. PubMed ID: 23623309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function.
    Hubert N; Hentze MW
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12345-50. PubMed ID: 12209011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the mutations of the HFE gene and of the SLC11A3 gene on iron overload in Greek thalassemia intermedia and beta(s)/beta(thal) anemia patients.
    Politou M; Kalotychou V; Pissia M; Rombos Y; Sakellaropoulos N; Papanikolaou G
    Haematologica; 2004 Apr; 89(4):490-2. PubMed ID: 15075083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between erythropoiesis and bone metabolism in thalassemia.
    Pootrakul P; Hungsprenges S; Fucharoen S; Baylink D; Thompson E; English E; Lee M; Burnell J; Finch C
    N Engl J Med; 1981 Jun; 304(24):1470-3. PubMed ID: 7231478
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
    Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
    Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron absorption in the thalassemia syndromes.
    Nutr Rev; 1979 May; 37(5):138-40. PubMed ID: 492599
    [No Abstract]   [Full Text] [Related]  

  • 20. Disruption of ferroportin 1 regulation causes dynamic alterations in iron homeostasis and erythropoiesis in polycythaemia mice.
    Mok H; Jelinek J; Pai S; Cattanach BM; Prchal JT; Youssoufian H; Schumacher A
    Development; 2004 Apr; 131(8):1859-68. PubMed ID: 15084469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.